期刊文献+

正常脾脏与肝硬化脾脏组织基因表达概况分析 被引量:2

Gene expression profile in normal and cirrhotic spleen tissues
原文传递
导出
摘要 目的 了解正常脾脏与肝硬化脾脏的基因表达概况 ,寻找在两者之间的差异表达基因。方法 以正常脾脏及肝硬化脾脏组织的总RNA反转录合成含有α 3 2 PdATP的cDNA为探针 ,与Atlas微阵列表达分析膜进行差异杂交。结果 放射自显影结果经AtlasImageTM 软件分析显示 :在所分析的 5 88种已知基因中 ,CK8、ICE LAP6、PISSLARE等 32个在肝硬化脾脏组织中表达上调 ,byglycan、Caspase 10、CRAF 1等 45个表达下调 ,参与细胞增殖、凋亡、分化、细胞间相互作用 ,与细胞侵袭相关的基因表达水平发生了明显改变。结论 通过Atlas微阵列系统分析发现的这些基因的表达改变组成了一个不同情况下脾脏特异的基因表达谱 ,是人类首次全面系统地研究脾脏的基因表达改变 ,一些与脾脏变化有关的差异表达基因 ,对彻底了解脾脏在肝硬化过程中的变化及其所发挥的作用有重要的意义。Atlas微阵列技术的应用将为人类了解疾病的发生、发展过程提供一个较好的方法。 Objective To describe a spleen specific gene expression profile and identify genes showing expression differences between normal and cirrhotic spleen tissues. Methods The cDNA probe labeled with α 32 P dATP was synthesized from total RNA of 28 samples of normal and cirrhotic spleen tissues. Then it was separately hybridized to two identified Atlas human cancer cDNA expression array membranes containing 588 known genes. Results Autoradiographic results were analyzed by specific AtlasImage TM (version 1 01a) software. Amongst the 588 genes, 32 including CK8, ICE LAP6 and PISSLARE etc. were up regulated and 45 including byglycan, Caspase 10 and CRAF 1 etc. were down regulated in cirrhotic spleen. The most significant changes were found in expression levels of genes associated with the regulation of cell proliferation, apoptosis, differentiation and cell cell interaction as well as invasion regulators and cytokines. Conclusions The results obtained from Atlas microarray provide a comprehensive spleen specific gene expression profile in different situations. Some modified genes may be helpful for finding the effect of spleen on liver cirrhosis. Microarray is a useful method to find the onset and progression of many diseases.
出处 《中华肝胆外科杂志》 CAS CSCD 2002年第1期37-41,共5页 Chinese Journal of Hepatobiliary Surgery
基金 国家攀登计划 (No . 18) 86 3(z19-0 1-0 1-12 )课题资助
关键词 基因表达谱 脾脏 差异杂交 Atlas微阵列 肝硬化 实验研究 Gene expression Spleen Hybridization Microarray
  • 相关文献

参考文献14

  • 1Schena M;Shalon D;Davis RW.Quantitative monitoring of gene expression patterns with a complementary DNA microarray[J],1995(5235).
  • 2Anand Apte B;Bao L;Smith R.A review of tissue inhibitor of metalloproteinases-3 (TIMP-3) and experimental analysis of its effect on primary tumor growth,1996(74).
  • 3Dixon SC;Kruger EA;Bauer KS.Thalidomide up-regulates prostate-specific antigen secretion from LNCaP cells[J],1999.
  • 4Kashiwada M;Kaneko Y;Yagita H.Activation of mitogen-activated protein kinases via CD40 is distinct from that stimulated by surface IgM on B cells[J],1996.
  • 5Wojnowski L;Zimmer AM;Beck TW.Endothelial apoptosis in Braf-deficient mice[J],1997.
  • 6Okuda T;Cleveland JL;Downing JR.PCTAIRE-1 and PCTAIRE-3,two members of a novel cdc2/CDC28-related protein kinase gene family,1992.
  • 7Faissner A.The tenascin gene family in axon growth and guidance[J],1997.
  • 8Liguori G;Gregorio L;Tucci M.Mapping of the mouse Tdgf1 gene and Tdgf pseudogenes[J],1997.
  • 9Lakowski B;Hekimi S.Determination of life-span in caenorhabditis elegans by four clock genes[J],1996.
  • 10Li P;Nijhawan D;Budihardjo I.Cytochrome C and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade[J],1997.

共引文献15

同被引文献24

  • 1Than TH, Swethadri GK, Wong J, et al. Expression of galectin- 3 and galectin-7 in thyroid malignancy as potential diagnostic indicators [ J ]. Singapore Med J, 2008,49 (4) : 333-338.
  • 2Janicke RU, Sohn D, Totzke G, et al. Caspase-10 in mouse or not [J]? Science,2006,312(5782) : 1874.
  • 3Cermti E, Campagnoli MF, Ferretti M, et al. Co-inherited mutations of Fas and caspase-lO in development of the autoimmune lymphoproliferative syndrome [J]. BMC Immunol, 2007,8( 1 ) :28-37.
  • 4Yang S, Zhou Q, Yang x. Caspase-3 status is a determinant of the differential responses to genistein between MDA-MB-231 and MCF-7 breast cancer cells [ J ]. Biochim Biophys Acta,2007, 1773 (6) :903-911.
  • 5Lan Q, Zheng T, Chanock S, et al. Genetic variants in caspase genes and susceptibility to non - Hodgkin lymphoma [J ]. Carcinogenesis, 2007,28 (4) : 823-827.
  • 6Park WS, Lee JH, Shin MS, et al. Inactivating mutations of the caspase- 10 gene in gastric cancer [ J ]. Oncogene, 2002,21 ( 18 ) : 2919-2925.
  • 7Mitsiades N, Poulaki V, Tseleni-Balafouta S, et al. Thyroid carcinoma cells are resistant to FAS-mediated apoptosis but sensitive to tumor necrosis factor-related apoptosis-inducing ligand[J]. Cancer Res,2000,60(15) :4122-4129.
  • 8Dumont P, lngrassia L, Rouzeau S, et al. The Amaryllidaceae isocarbostyril narciclasine induces apoptosis by activation of the death receptor and/or mitochondrial pathways in cancer cells but not in normal fibroblasts[J]. Neoplasia,2007,9(9) :766-776.
  • 9Walczak H, Haas TL. Biochemical analysis of the native TRAIL death-inducing signaling complex [ J ]. Methods Mol Biol, 2008, 414:221-239.
  • 10Wang H, Wang P, Sun X, et al. Cloning and characterization of a novel caspase-10 isoform that activates NF-kappa B activity[J]. Biochim Biophys Acta,2007,1770( 11 ) : 1528-1537.

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部